Đang chuẩn bị liên kết để tải về tài liệu:
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The patterns and determinants of saxagliptin use among patients with type 2 diabetes mellitus (T2DM) are unknown in real-world settings. We compared the characteristics of T2DM patients who were new initiators of saxagliptin to those who were new initiators of non-dipeptidyl peptidase-4 (DPP-4) inhibitor oral anti-diabetic drugs (OADs) and identified factors associated with saxagliptin use. | Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs